Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
Stem cell transplantation and cardiac regeneration after myocardial infarction in SCID mice: Human MAPCs are effective and safe. [electronic resource] by
- Groebner, M
- Deindl, L
- Dimomeletis, I
- Zaruba, Mm
- Kostin, S
- Deutsch, Ma
- Assmann, G
- Mueller-Hocker, J
- Feuring-Buske, M
- Franz, Wm
Producer: 20140620
In:
Journal of stem cells & regenerative medicine vol. 2
Availability: No items available.
|
|
38.
|
GPR56 contributes to the development of acute myeloid leukemia in mice. [electronic resource] by
- Daria, D
- Kirsten, N
- Muranyi, A
- Mulaw, M
- Ihme, S
- Kechter, A
- Hollnagel, M
- Bullinger, L
- Döhner, K
- Döhner, H
- Feuring-Buske, M
- Buske, C
Producer: 20170828
In:
Leukemia vol. 30
Availability: No items available.
|
|
39.
|
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. [electronic resource] by
- Coiffier, B
- Haioun, C
- Ketterer, N
- Engert, A
- Tilly, H
- Ma, D
- Johnson, P
- Lister, A
- Feuring-Buske, M
- Radford, J A
- Capdeville, R
- Diehl, V
- Reyes, F
Producer: 19981006
In:
Blood vol. 92
Availability: No items available.
|
|
40.
|
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group. [electronic resource] by
- Feuring-Buske, M
- Kneba, M
- Unterhalt, M
- Engert, A
- Gramatzki, M
- Hiller, E
- Trümper, L
- Brugger, W
- Ostermann, H
- Atzpodien, J
- Hallek, M
- Aulitzky, E
- Hiddemann, W
Producer: 20001031
In:
Annals of hematology vol. 79
Availability: No items available.
|